Bin Li, Ph.D.

EVP, Chemistry R&D

Dr. Bin Li brings over 20 years of extensive experience in drug discovery and development. After received his Ph.D. degree from Shanghai Institute of Organic Chemistry (SIOC) under the guidance of the renowned professor Li-Xin Dai in 2001, Bin started his career as a medicinal chemist at Neurocrine Biosciences, and then made a change to become a process chemist in 2005. After 10 years at Neurocrine working on the development of Orilissa (Elagolix) and Ingrezza (Valbenazine) to the market, Bin joined Agno Pharma in 2010 overseeing the Chemistry R&D department. Specializing in chiral synthesis and enzymatic chemistry, Bin has consistently met and exceeded client expectations across North America and Europe.